eCOA Solutions In Oncology: How To Avoid Common Pitfalls And Ensure The Success Of Long-Term Studies?

Conducting oncology studies is becoming more and more difficult. The rising complexity of protocol design, the difficulty to identify meaningful endpoints, and the increasing volume of those endpoints combine to generate a significant level of complexity. To add to this, the competition between clinical trials at the level of the study sites and the multiplicity of tools and systems to run a given study are also factors that have a significant impact on the implementation and conduct of clinical studies at clinical cancer centers. A 2019 report showed that despite accounting for almost 30% of the R&D product pipeline in 2018, composite success rates for oncology studies are only 8%.